Clin2
NCT02423395Possibly a fitRecruiting

Orphenadrine for muscle cramps in people with cirrhosis

Liver CirrhosisMuscle Cramps

Part of Bones, joints & muscles, Brain & nervous system, Digestive system clinical trials.

This trial tests whether orphenadrine (a medication used to reduce muscle cramping) can lessen muscle cramps in people who have cirrhosis of the liver. It may help if your cramps happen often, but you must avoid certain medication conflicts and health situations.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
100 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have cirrhosis (scarring of the liver).
  • You have muscle cramps at least 3 times per week.
  • You are not allergic to orphenadrine.
  • You do not have significant kidney problems.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06814626Recruiting· Phase 3
Nutrition therapy for muscle loss in cirrhosis with fluid buildup

This trial tests whether a special nutrition plan can help treat muscle loss in people with liver cirrhosis who also have fluid buildup that doesn't improve with standard treatment. It aims to improve strength and outcomes after a procedure to place a shunt in the liver.

Palermo
NCT07726693Not yet recruiting· Phase 3
Apixaban to prevent early liver cirrhosis complications

This trial tests if the blood thinner apixaban can prevent liver cirrhosis from getting worse in people with alcohol-related liver disease. It may help reduce the risk of serious complications like fluid buildup or bleeding.

NCT04448028Recruiting· Phase 4
Stopping acid pills in liver cirrhosis: test placebo effect

This study tests whether stopping proton-pump inhibitor (PPI) acid-reducing medication is safe and works as expected for people with liver cirrhosis. Participants switch to either the study medication or a placebo (inactive pill) under close monitoring.

Hamburg, Free and Hanseatic City of Hamburg
NCT06527222Recruiting· Phase 2
Ranolazine for muscle cramps in ALS

This trial tests if a heart medication called ranolazine can reduce painful muscle cramps in people with ALS. If you experience frequent cramps and meet the other criteria, this study may be an option for you.

San Francisco, California
NCT05166499Recruiting
Amino acids to help rebuild muscle in liver cirrhosis

This trial tests whether a special amino-acid supplement can help reverse muscle loss in people with cirrhosis (scarring of the liver). It may help maintain or improve muscle strength and overall function, but eligibility depends on your liver status and overall health.

Cleveland, Ohio
NCT06966843Not yet recruiting· Phase 2/Phase 3
Studying dantrolene for statin-related muscle pain

This trial tests whether dantrolene can relieve muscle pain or weakness caused by statin medications. If you have muscle symptoms and high creatine kinase levels, this study may help find a treatment option.

Hear when a new Liver Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.